Testing a new combination drug in healthy adults
This trial tests a new combination drug (AG2304) compared to taking two separate drugs together. It's for healthy adults to see how the body handles the drugs and check for safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 65 years old.
- You are in good general health.
- You have not taken any experimental drug in the last 6 months.
- You meet other health screening criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new version of a drug (AG2202) works the same way in the body as the original. It is for healthy volunteers to check how the drug is absorbed and processed.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This trial studies how two experimental drugs (AD-2321 and AD-2322) interact in the body and if they are safe for healthy volunteers. It is a Phase 1 study open to healthy adults.
This is an early-stage study testing a new medicine called GR2301 given as multiple injections. Researchers want to see how safe it is and how the body handles it in healthy volunteers with no serious medical conditions.
This trial tests a new drug called GR2303 to see if it is safe and how the body processes it. It is for healthy adults who have not used similar drugs before.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
Hear when a new Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.